down arrow

Mankind Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,340.80
10.45 (0.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.22 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Abbott India
Cipla
Lupin
Zydus Lifesci.
Alkem Lab
Dr Reddy's Labs
Sun Pharma.Inds.
Torrent Pharma
Aurobindo Pharma
Mankind Pharma
Why is Mankind Pharma Ltd ?
1
The company has declared negative results in Dec 24 after 6 consecutive negative quarters
  • PAT(Q) At Rs 380.23 cr has Fallen at -28.1 %
  • INTEREST(Q) At Rs 220.93 cr has Grown at 3,011.69 %
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 3.76 times
2
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 08-Apr-25
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
With ROE of 20, it has a Very Expensive valuation with a 9.1 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -0.95%, its profits have risen by 49%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Mankind Pharma for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Mankind Pharma
-1.14%
-0.03
32.96%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
18.50%
EBIT Growth (5y)
11.80%
EBIT to Interest (avg)
35.25
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.06
Tax Ratio
20.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.37%
ROCE (avg)
30.29%
ROE (avg)
19.25%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
47
Industry P/E
33
Price to Book Value
9.10
EV to EBIT
37.63
EV to EBITDA
31.12
EV to Capital Employed
14.54
EV to Sales
7.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
36.42%
ROE (Latest)
20.02%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NET SALES(Q)

Highest at Rs 3,230.00 cr

-21What is not working for the Company
PAT(Q)

At Rs 380.23 cr has Fallen at -28.1 %

INTEREST(Q)

At Rs 220.93 cr has Grown at 3,011.69 %

OPERATING PROFIT TO INTEREST (Q)

Lowest at 3.76 times

PBT LESS OI(Q)

Lowest at Rs 420.01 cr.

EPS(Q)

Lowest at Rs 9.49

Loading Valuation Snapshot...
Here's what is working for Mankind Pharma
Net Sales - Quarterly
Highest at Rs 3,230.00 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Mankind Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 420.01 cr has Fallen at -26.3 %
over average PBT of the previous four quarters of Rs 569.64 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 380.23 cr has Fallen at -28.1 %
over average PAT of the previous four quarters of Rs 528.74 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Quarterly
At Rs 220.93 cr has Grown at 3,011.69 %
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Operating Profit to Interest - Quarterly
Lowest at 3.76 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest - Quarterly
Highest at Rs 220.93 cr
in the last five quarters and Increased by 3,011.69 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 420.01 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 9.49
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."